Novel Therapeutic Approaches for Small Cell Lung Cancer: The Future has Arrived

Por Pietanza, M. Catherine, Rudin, Charles M.
Publicado em 2012

Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?

Por Pietanza, M. Catherine, Byers, Lauren Averett, Minna, John D., Rudin, Charles M.
Publicado no Clin Cancer Res (2015)

Q-TWiST Analysis to Assess Benefit–Risk of Pembrolizumab in Patients with PD-L1–Positive Advanced or Metastatic Non-small Cell Lung Cancer

Por Huang, Min, Pietanza, M. Catherine, Samkari, Ayman, Pellissier, James, Burke, Thomas, Chandwani, Sheenu, Kong, Fansen, Pickard, A. Simon
Publicado no Pharmacoeconomics (2018)

Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial

Por Basch, Ethan, Wood, William A, Schrag, Deborah, Sima, Camelia S, Shaw, Mary, Rogak, Lauren J, Kris, Mark G, Shouery, Marwan, Bennett, Antonia, Atkinson, Thomas, Pietanza, M Catherine
Publicado no Clin Trials (2015)

EGFR mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib

Por Chmielecki, Juliann, Pietanza, M. Catherine, Aftab, Dana, Shen, Ronglai, Zhao, Zhiguo, Chen, Xi, Hutchinson, Katherine, Viale, Agnes, Kris, Mark G., Stout, Thomas, Miller, Vincent, Rizvi, Naiyer, Pao, William
Publicado em 2012

Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas

Por D'Angelo, Sandra P., Pietanza, M. Catherine, Johnson, Melissa L., Riely, Gregory J., Miller, Vincent A., Sima, Camelia S., Zakowski, Maureen F., Rusch, Valerie W., Ladanyi, Marc, Kris, Mark G.
Publicado em 2011

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma – rationale for comprehensive mutation profiling

Por Chaft, Jamie E., Arcila, Maria E., Paik, Paul K., Lau, Christopher, Riely, Gregory J., Pietanza, M. Catherine, Zakowski, Maureen F., Rusch, Valerie, Sima, Camelia, Ladanyi, Marc, Kris, Mark G.
Publicado em 2011

Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized con...

Por Borghaei, Hossein, Langer, Corey J., Paz‐Ares, Luis, Rodríguez‐Abreu, Delvys, Halmos, Balazs, Garassino, Marina C., Houghton, Baerin, Kurata, Takayasu, Cheng, Ying, Lin, Jianxin, Pietanza, M. Catherine, Piperdi, Bilal, Gadgeel, Shirish M.
Publicado no Cancer (2020)

BRIEF REPORT: SMALL CELL LUNG CANCERS IN PATIENTS WHO NEVER SMOKED CIGARETTES

Por Varghese, Anna M., Zakowski, Maureen F., Yu, Helena A., Won, Helen H., Riely, Gregory J., Krug, Lee M., Kris, Mark G., Rekhtman, Natasha, Ladanyi, Marc, Wang, Lu, Berger, Michael F., Pietanza, M. Catherine
Publicado em 2014

Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistance to EGFR tyr...

Por Yu, Helena A., Sima, Camelia S., Huang, James, Solomon, Stephen B., Rimner, Andreas, Paik, Paul, Pietanza, M. Catherine, Azzoli, Christopher G., Rizvi, Naiyer A., Krug, Lee M., Miller, Vincent A., Kris, Mark G., Riely, Gregory J.
Publicado em 2013

Patterns of failure in limited-stage small cell lung cancer: implications of TNM stage for prophylactic cranial irradiation

Por Wu, Abraham J., Gillis, Andrea, Foster, Amanda, Woo, Kaitlin, Zhang, Zhigang, Gelblum, Daphna Y., Downey, Robert J., Rosenzweig, Kenneth E., Ong, Leonard, Perez, Carmen A., Pietanza, M. Catherine, Krug, Lee, Rudin, Charles M., Rimner, Andreas
Publicado no Radiother Oncol (2017)

Trial of a 5-Day Dosing Regimen of Temozolomide in Patients with Relapsed Small Cell Lung Cancers with Assessment of Methylguanine-DNA Methyltransferase

Por Zauderer, Marjorie G., Drilon, Alex, Kadota, Kyuichi, Huberman, Kety, Sima, Camelia S., Bergagnini, Isabella, Sumner, Dyana K., Travis, William D., Heguy, Adriana, Ginsberg, Michelle S., Holodny, Andrei I., Riely, Gregory J., Kris, Mark G., Krug, Lee M., Pietanza, M. Catherine
Publicado no Lung Cancer (2014)

A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer

Por Pietanza, M. Catherine, Litvak, Anya M., Varghese, Anna M., Krug, Lee M., Fleisher, Martin, Teitcher, Jerrold B., Holodny, Andrei I., Sima, Cami S., Woo, Kaitlin M., Ng, Kenneth K., Won, Helen H., Berger, Michael F., Kris, Mark G., Rudin, Charles M.
Publicado no Lung Cancer (2016)

Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

Por Taylor, Matthew, Antonia, Scott, Bendell, Johanna, Calvo, Emiliano, Jäger, Dirk, de Braud, Filippo, Ott, Patrick A, Pietanza, M Catherine, Horn, Leora, Le, Dung T, Morse, Michael A, López-Martin, José A, Ascierto, Paolo A, Christensen, Olaf, Simon, Jason S, Lin, Chen-Sheng, Eder, Joseph Paul
Publicado no J Immunother Cancer (2015)

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Por Rudin, Charles M., Awad, Mark M., Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csőszi, Tibor, Cheema, Parneet K., Rodriguez-Abreu, Delvys, Wollner, Mirjana, Yang, James Chih-Hsin, Mazieres, Julien, Orlandi, Francisco J., Luft, Alexander, Gümüş, Mahmut, Kato, Terufumi, Kalemkerian, Gregory P., Luo, Yiwen, Ebiana, Victoria, Pietanza, M. Catherine, Kim, Hye Ryun
Publicado no J Clin Oncol (2020)

Harnessing Technology to Improve Clinical Trials: Study of Real-Time Informatics to Collect Data, Toxicities, Image Response Assessments, and Patient-Reported Outcomes in a Phase I...

Por Pietanza, M. Catherine, Basch, Ethan M., Lash, Alex, Schwartz, Lawrence H., Ginsberg, Michelle S., Zhao, Binsheng, Shouery, Marwan, Shaw, Mary, Rogak, Lauren J., Wilson, Manda, Gabow, Aaron, Latif, Marcia, Lin, Kai-Hsiung, Wu, Qinfei, Kass, Samantha L., Miller, Claire P., Tyson, Leslie, Sumner, Dyana K., Berkowitz-Hergianto, Alison, Sima, Camelia S., Kris, Mark G.
Publicado no J Clin Oncol (2013)

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

Por Rudin, Charles M, Pietanza, M Catherine, Bauer, Todd M, Ready, Neal, Morgensztern, Daniel, Glisson, Bonnie S, Byers, Lauren A, Johnson, Melissa L, Burris, Howard A, Robert, Francisco, Han, Tae H, Bheddah, Sheila, Theiss, Noah, Watson, Sky, Mathur, Deepan, Vennapusa, Bharathi, Zayed, Hany, Lally, Satwant, Strickland, Donald K, Govindan, Ramaswamy, Dylla, Scott J, Peng, Stanford L, Spigel, David R
Publicado no Lancet Oncol (2016)

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

Por Pietanza, M. Catherine, Waqar, Saiama N., Krug, Lee M., Dowlati, Afshin, Hann, Christine L., Chiappori, Alberto, Owonikoko, Taofeek K., Woo, Kaitlin M., Cardnell, Robert J., Fujimoto, Junya, Long, Lihong, Diao, Lixia, Wang, Jing, Bensman, Yevgeniva, Hurtado, Brenda, de Groot, Patricia, Sulman, Erik P., Wistuba, Ignacio I., Chen, Alice, Fleisher, Martin, Heymach, John V., Kris, Mark G., Rudin, Charles M., Byers, Lauren Averett
Publicado no J Clin Oncol (2018)

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Por Saunders, Laura R., Bankovich, Alexander J., Anderson, Wade C., Aujay, Monette A., Bheddah, Sheila, Black, KristenAnn, Desai, Radhika, Escarpe, Paul A., Hampl, Johannes, Laysang, Amy, Liu, David, Lopez-Molina, Javier, Milton, Milly, Park, Albert, Pysz, Marybeth A., Shao, Hui, Slingerland, Brian, Torgov, Michael, Williams, Samuel A., Foord, Orit, Howard, Philip, Jassem, Jacek, Badzio, Andrzej, Czapiewski, Piotr, Harpole, David H., Dowlati, Afshin, Massion, Pierre P., Travis, William D., Pietanza, M. Catherine, Poirier, J. T., Rudin, Charles M., Stull, Robert A., Dylla, Scott J.
Publicado no Sci Transl Med (2015)

Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?

Por Bunn, Paul A., Minna, John, Augustyn, Alexander, Gazdar, Adi, Ouadah, Youcef, Krasnow, Mark A., Berns, Anton, Brambilla, Elisabeth, Rekhtman, Natasha, Massion, Pierre P., Niederst, Matthew, Peifer, Martin, Yokota, Jun, Govindan, Ramaswamy, Poirier, John, Byers, Lauren A., Wynes, Murry W., McFadden, David, MacPherson, David, Hann, Christine L., Farago, Anna F., Dive, Caroline, Teicher, Beverly A., Peacock, Craig, Johnson, Jane E., Cobb, Melanie H., Wendel, Hans-Guido, Spigel, David, Sage, Julien, Yang, Ping, Pietanza, M. Catherine, Krug, Lee M., Heymach, John, Ujhazy, Peter, Zhou, Caicun, Goto, Koichi, Dowlati, Afshin, Christensen, Camilla Laulund, Park, Keunchil, Einhorn, Lawrence H., Edelman, Martin J., Giaccone, Giuseppe, Gerber, David E., Salgia, Ravi, Owonikoko, Taofeek, Malik, Shakun, Karachaliou, Niki, Gandara, David R., Slotman, Ben J., Blackhall, Fiona, Goss, Glenwood, Thomas, Roman, Rudin, Charles M., Hirsch, Fred. R.
Publicado no J Thorac Oncol (2016)